253 related articles for article (PubMed ID: 18338820)
41. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
Draube A; Beyer M; Schumer S; Thomas RK; von Tresckow B; Koslowsky TC; Krieglstein CF; Schultze JL; Wolf J
J Immunother; 2007; 30(4):359-69. PubMed ID: 17457211
[TBL] [Abstract][Full Text] [Related]
42. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
43. Efficient genetic modification of murine dendritic cells by electroporation with mRNA.
Van Meirvenne S; Straetman L; Heirman C; Dullaers M; De Greef C; Van Tendeloo V; Thielemans K
Cancer Gene Ther; 2002 Sep; 9(9):787-97. PubMed ID: 12189529
[TBL] [Abstract][Full Text] [Related]
44. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
[TBL] [Abstract][Full Text] [Related]
45. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
Odunsi K; Qian F; Matsuzaki J; Mhawech-Fauceglia P; Andrews C; Hoffman EW; Pan L; Ritter G; Villella J; Thomas B; Rodabaugh K; Lele S; Shrikant P; Old LJ; Gnjatic S
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12837-42. PubMed ID: 17652518
[TBL] [Abstract][Full Text] [Related]
46. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
Michiels A; Tuyaerts S; Bonehill A; Corthals J; Breckpot K; Heirman C; Van Meirvenne S; Dullaers M; Allard S; Brasseur F; van der Bruggen P; Thielemans K
Gene Ther; 2005 May; 12(9):772-82. PubMed ID: 15750615
[TBL] [Abstract][Full Text] [Related]
47. Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals.
Valmori D; Souleimanian NE; Hesdorffer CS; Old LJ; Ayyoub M
Clin Immunol; 2005 Nov; 117(2):161-7. PubMed ID: 16103015
[TBL] [Abstract][Full Text] [Related]
48. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
49. Optimizing nonviral-mediated transfection of human intervertebral disc chondrocytes.
Morrey ME; Anderson PA; Chambers G; Paul R
Spine J; 2008; 8(5):796-803. PubMed ID: 18023624
[TBL] [Abstract][Full Text] [Related]
50. Successful gene transfer into dendritic cells with cationized gelatin and plasmid DNA complexes via a phagocytosis-dependent mechanism.
Inada S; Fujiwara H; Atsuji K; Takashima K; Araki Y; Kubota T; Tabata Y; Yamagishi H
Anticancer Res; 2006; 26(3A):1957-63. PubMed ID: 16827130
[TBL] [Abstract][Full Text] [Related]
51. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.
van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM
Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343
[TBL] [Abstract][Full Text] [Related]
52. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.
Nishimoto KP; Tseng SY; Lebkowski JS; Reddy A
Regen Med; 2011 May; 6(3):303-18. PubMed ID: 21548736
[TBL] [Abstract][Full Text] [Related]
53. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
Ayyoub M; Souleimanian NE; Godefroy E; Scotto L; Hesdorffer CS; Old LJ; Valmori D
Clin Immunol; 2006; 118(2-3):188-94. PubMed ID: 16368270
[TBL] [Abstract][Full Text] [Related]
54. Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation.
Koido S; Ohana M; Liu C; Nikrui N; Durfee J; Lerner A; Gong J
Clin Immunol; 2004 Dec; 113(3):261-9. PubMed ID: 15507391
[TBL] [Abstract][Full Text] [Related]
55. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
56. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
[TBL] [Abstract][Full Text] [Related]
57. HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
Bioley G; Guillaume P; Luescher I; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Valmori D; Ayyoub M
Clin Cancer Res; 2009 Jan; 15(1):299-306. PubMed ID: 19118058
[TBL] [Abstract][Full Text] [Related]
58. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
[TBL] [Abstract][Full Text] [Related]
59. Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen.
Valmori D; Lévy F; Godefroy E; Scotto L; Souleimanian NE; Karbach J; Tosello V; Hesdorffer CS; Old LJ; Jager E; Ayyoub M
Clin Immunol; 2007 Feb; 122(2):163-72. PubMed ID: 17064965
[TBL] [Abstract][Full Text] [Related]
60. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
